139 related articles for article (PubMed ID: 8404911)
1. Evaluation of agents for use in medium for selective isolation of Lyme disease and relapsing fever Borrelia species.
Morshed MG; Konishi H; Nishimura T; Nakazawa T
Eur J Clin Microbiol Infect Dis; 1993 Jul; 12(7):512-8. PubMed ID: 8404911
[TBL] [Abstract][Full Text] [Related]
2. Isolation of Borrelia miyamotoi and other Borreliae using a modified BSK medium.
Replogle AJ; Sexton C; Young J; Kingry LC; Schriefer ME; Dolan M; Johnson TL; Connally NP; Padgett KA; Petersen JM
Sci Rep; 2021 Jan; 11(1):1926. PubMed ID: 33479281
[TBL] [Abstract][Full Text] [Related]
3. Comparison of isolation rate of Borrelia burgdorferi sensu lato in two different culture media, MKP and BSK-H.
Ružić-Sabljić E; Maraspin V; Cimperman J; Strle F; Lotrič-Furlan S; Stupica D; Cerar T
Clin Microbiol Infect; 2014 Jul; 20(7):636-41. PubMed ID: 24237688
[TBL] [Abstract][Full Text] [Related]
4. In vitro evaluation of combined usage of fosfomycin and 5-fluorouracil for selective isolation of Leptospira species.
Oie S; Koshiro A; Konishi H; Yoshii Z
J Clin Microbiol; 1986 Jun; 23(6):1084-7. PubMed ID: 3519669
[TBL] [Abstract][Full Text] [Related]
5. Development and optimization of an in vitro cultivation protocol allows for isolation of Borrelia miyamotoi from patients with hard tick-borne relapsing fever.
Koetsveld J; Kolyasnikova NM; Wagemakers A; Toporkova MG; Sarksyan DS; Oei A; Platonov AE; Hovius JW
Clin Microbiol Infect; 2017 Jul; 23(7):480-484. PubMed ID: 28110053
[TBL] [Abstract][Full Text] [Related]
6. Uptake and killing of Lyme disease and relapsing fever borreliae in the perfused rat liver and by isolated Kupffer cells.
Sambri V; Aldini R; Massaria F; Montagnani M; Casanova S; Cevenini R
Infect Immun; 1996 May; 64(5):1858-61. PubMed ID: 8613404
[TBL] [Abstract][Full Text] [Related]
7. Laboratory Cultivation and Maintenance of Borrelia miyamotoi.
Stone BL; Brissette CA
Curr Protoc Microbiol; 2016 Aug; 42():12F.1.1-12F.1.6. PubMed ID: 27517334
[TBL] [Abstract][Full Text] [Related]
8. In vitro activity of trimethoprim against Borrelia burgdorferi.
Reisinger EC; Wendelin I; Gasser R
Eur J Clin Microbiol Infect Dis; 1997 Jun; 16(6):458-60. PubMed ID: 9248750
[TBL] [Abstract][Full Text] [Related]
9. A phylogenomic and molecular marker based proposal for the division of the genus Borrelia into two genera: the emended genus Borrelia containing only the members of the relapsing fever Borrelia, and the genus Borreliella gen. nov. containing the members of the Lyme disease Borrelia (Borrelia burgdorferi sensu lato complex).
Adeolu M; Gupta RS
Antonie Van Leeuwenhoek; 2014 Jun; 105(6):1049-72. PubMed ID: 24744012
[TBL] [Abstract][Full Text] [Related]
10. Phylogenetic analysis of Borrelia species based on flagellin gene sequences and its application for molecular typing of Lyme disease borreliae.
Fukunaga M; Okada K; Nakao M; Konishi T; Sato Y
Int J Syst Bacteriol; 1996 Oct; 46(4):898-905. PubMed ID: 8863416
[TBL] [Abstract][Full Text] [Related]
11. Variations in Barbour-Stoenner-Kelly culture medium modulate infectivity and pathogenicity of Borrelia burgdorferi clinical isolates.
Wang G; Iyer R; Bittker S; Cooper D; Small J; Wormser GP; Schwartz I
Infect Immun; 2004 Nov; 72(11):6702-6. PubMed ID: 15501807
[TBL] [Abstract][Full Text] [Related]
12. A new Borrelia species isolated from patients with relapsing fever in Spain.
Anda P; Sánchez-Yebra W; del Mar Vitutia M; Pérez Pastrana E; Rodríguez I; Miller NS; Backenson PB; Benach JL
Lancet; 1996 Jul; 348(9021):162-5. PubMed ID: 8684157
[TBL] [Abstract][Full Text] [Related]
13. In vitro susceptibility of thirty Borrelia strains from various sources against eight antimicrobial chemotherapeutics.
Baradaran-Dilmaghani R; Stanek G
Infection; 1996; 24(1):60-3. PubMed ID: 8852472
[TBL] [Abstract][Full Text] [Related]
14. Inactivation of diaminopyrimidines and sulfonamides in Barbour-Stoenner-Kelly medium for isolation of Borrelia burgdorferi.
Reisinger EC; Wendelin I; Gasser R
Eur J Clin Microbiol Infect Dis; 1995 Aug; 14(8):732-3. PubMed ID: 8566001
[No Abstract] [Full Text] [Related]
15. European Borrelia burgdorferi isolated from humans and ticks culture conditions and antibiotic susceptibility.
Preac-Mursic V; Wilske B; Schierz G
Zentralbl Bakteriol Mikrobiol Hyg A; 1986 Dec; 263(1-2):112-8. PubMed ID: 3577473
[TBL] [Abstract][Full Text] [Related]
16. Lyme disease and relapsing fever Borrelia elongate through zones of peptidoglycan synthesis that mark division sites of daughter cells.
Jutras BL; Scott M; Parry B; Biboy J; Gray J; Vollmer W; Jacobs-Wagner C
Proc Natl Acad Sci U S A; 2016 Aug; 113(33):9162-70. PubMed ID: 27506799
[TBL] [Abstract][Full Text] [Related]
17. Molecular biology of antigenic variation in Lyme borreliosis and relapsing fever: a comparative analysis.
Barbour AG
Scand J Infect Dis Suppl; 1991; 77():88-93. PubMed ID: 1947817
[TBL] [Abstract][Full Text] [Related]
18. Comparison of growth of Borrelia afzelii, B. garinii, and B. burgdorferi sensu stricto in MKP and BSK-II medium.
Ruzić-Sabljić E; Strle F
Int J Med Microbiol; 2004 Oct; 294(6):407-12. PubMed ID: 15595391
[TBL] [Abstract][Full Text] [Related]
19. Borrelia sp. phylogenetically different from Lyme disease- and relapsing fever-related Borrelia spp. in Amblyomma varanense from Python reticulatus.
Trinachartvanit W; Hirunkanokpun S; Sudsangiem R; Lijuan W; Boonkusol D; Baimai V; Ahantarig A
Parasit Vectors; 2016 Jun; 9(1):359. PubMed ID: 27342652
[TBL] [Abstract][Full Text] [Related]
20. A novel combination of selective agents for isolation of Leptospira species.
Chakraborty A; Miyahara S; Villanueva SY; Saito M; Gloriani NG; Yoshida S
Microbiol Immunol; 2011 Jul; 55(7):494-501. PubMed ID: 21545510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
